J Urgen Stoltefuss

Title: Innovator Spotlight: J Urgen Stoltefuss and His Contributions to Medicinal Chemistry

Introduction: J Urgen Stoltefuss, an accomplished inventor based in Haan, Germany, has made significant contributions to the field of medicinal chemistry. With a total of four patents to his name, his work demonstrates a commitment to advancing healthcare through innovative chemical solutions.

Latest Patents: Stoltefuss's latest patents focus on two important compounds. The first patent is for "3-quinolyl-substituted dihydropyridines, and their use in medicaments." This invention relates to derivatives of 3-quinolyl-substituted dihydropyridine, including pharmaceutically acceptable salts that are utilized in the treatment of cardiovascular diseases. The second patent is for "4-amino-3-hydroxy-phthalimidine, and a process for the preparation." This invention is crucial for synthesizing 3-substituted 5-quinoline-carboxylic acid amides, providing a valuable intermediate in pharmaceutical development.

Career Highlights: J Urgen Stoltefuss has spent a significant portion of his career at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has positioned him at the forefront of medicinal innovation, allowing him to explore and develop new therapeutic compounds.

Collaborations: Throughout his career, Stoltefuss has collaborated with fellow inventors such as Alexander Straub and Siegfried Goldmann. These partnerships have fostered a dynamic environment of creativity and expertise, leading to impactful advancements in medicinal chemistry.

Conclusion: J Urgen Stoltefuss exemplifies dedication and innovation in the field of medicinal chemistry. Through his patents and collaborations, he continues to contribute to the development of novel therapeutics that hold promise for improving patient outcomes in cardiovascular and other health conditions. His work is a testament to the importance of inventors in shaping the future of medicine.